Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2013-04-04Clinical Trial Update: Secondary Prevention of Small Subcortical Strokes Trial [Phase 3]
Phase 3 trial update on secondary prevention of small subcortical strokes reports that the study has completed. The conditions involve cereb…
-
FDA approval · 2013-03-28FDA Approved: AMLODIPINE AND VALSARTAN — Original Application (Strides Pharma Science Limited)
The FDA approved Strides Pharma Science Limited's original application for a generic fixed-dose combination of amlodipine and valsartan for …
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated the weight and metabolic effects of an almond-enriched, hypocaloric, low-fat diet in overweight and obe…
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study [NA]
A completed clinical trial update on the MoMA Pre Prim Study examining mortality/morbidity outcomes in preeclamptic primiparas.
-
FDA approval · 2013-03-27FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
FDA approves a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) submitted by Organon LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: Hypertension Telemanagement in African Americans [NA]
A completed clinical trial evaluating hypertension telemanagement in African Americans conducted by Johns Hopkins University has been report…
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352) [Phase 3]
A Phase 3 trial of MK-0954A in Japanese patients with essential hypertension not adequately controlled by losartan has completed, with resul…
-
FDA approval · 2013-03-21FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original application for a generic fixed-dose combination of valsartan and hydrochlorothiazide manufactured by Alembic Phar…
-
FDA approval · 2013-03-21FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals’ original-application generic fixed-dose combination of valsartan and hydrochlorothiazide for hypertensio…
-
FDA approval · 2013-03-21FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's valsartan and hydrochlorothiazide as a generic combination tablet for treating hypertension under an…
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: Hemodynamics, Salt Sensitivity and Body Composition in Patients With Morbid Obesity
This completed clinical trial examined hemodynamics, salt sensitivity, and body composition in adults with morbid obesity. Hypertension was …
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes [Phase 4]
A Phase 4 trial evaluated adding Amlodipine or Chlorthalidone to Valturna versus Valturna alone in patients with stage 2 hypertension and di…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate [NA]
A terminated clinical trial in hypertension compared metoprolol and nebivolol on ambulatory blood pressure and basal metabolic rate, with re…
-
FDA approval · 2013-03-19FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from Teva Pharmaceuticals USA, Inc., under an AND…
-
CLINICAL_TRIALS research · 2013-03-19Clinical Trial Update: Renal Sympathetic Denervation in Patients With Hypertension and Paroxysmal Atrial Fibrillation [NA]
This clinical trial update covers renal sympathetic denervation for patients with hypertension and paroxysmal atrial fibrillation, with the …
-
FDA approval · 2013-03-18FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate from Aurobindo Pharma Limited under an ANDA.
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: ADAPT-Altering Diet for African American Populations to Treat Hypertension [NA]
A completed clinical trial evaluating an ADAPT-altering diet to treat hypertension in African American populations.
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans) [Phase 4]
Phase 4 clinical trial update on the DINE diet intervention aiming to improve weight loss outcomes for African Americans with diabetes and r…
-
FDA approval · 2013-03-14FDA Approved: LOPRESSOR — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for Lopressor (metoprolol tartrate) submitted by Validus Pharmaceuticals LLC.
-
FDA approval · 2013-03-14FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for the combination drug Losartan Potassium and Hydrochlorothiazide from Alembic Pharmaceuticals Lim…
-
FDA approval · 2013-03-12FDA Approved: DURACLON — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for DURACLON (clonidine hydrochloride) from Mylan Institutional LLC.
-
FDA approval · 2013-03-11FDA Approved: IRBESARTAN — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for IRBESARTAN submitted by NorthStar RxLLC under an ANDA. The approval pertains to the supplemental…
-
CLINICAL_TRIALS research · 2013-03-08Clinical Trial Update: Progression From Impaired Fasting Glucose to Type 2 Diabetes Mellitus Among Subjects With and Without Hypertension in Primary Care Setting
This completed clinical trial examined progression from impaired fasting glucose to Type 2 Diabetes Mellitus in adults, comparing outcomes f…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Ramipril - Hypertension [Phase 4]
Clinical trial update indicates Phase 4 Ramipril for hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects [Phase 1]
This Phase 1 pharmacokinetics study evaluated potential drug interactions of the HL-040XC fixed-dose combination tablet in healthy male subj…